Literature DB >> 1976067

N-depyridination and N-dedimethylaminoethylation of tripelennamine and pyrilamine in the rat. New metabolic pathways.

S Y Yeh1.   

Abstract

N-(2-Dimethylaminoethyl)benzylamine and 2-benzylaminopyridine were identified as two new urinary metabolites of tripelennamine in the rat by GC/MS. 2-(4-Methoxybenzylamino)-pyridine and N-(dimethylaminoethyl)-4-hydroxybenzylamine were identified as new urinary metabolites of pyrilamine by GC/MS. Thus, in addition to N- and O-demethylation, hydroxylation, and glucuronidation, N-debenzylation, N-depyridination and N-dedimethylaminoethylation were shown to be novel pathways for metabolism of tripelennamine and pyrilamine. The mechanism for N-depyridination and N-dealkylation is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976067

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  1 in total

1.  Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs.

Authors:  John Wilton; Elena Kurenova; Laura Pitzonka; Allison Gaudy; Leslie Curtin; Sandra Sexton; William Cance; Gerald Fetterly
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-11-07       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.